Financials data is unavailable for this security.
View more
Year on year Cambium Bio Ltd 's net income fell 33.72% from a loss of 1.69m to a larger loss of 2.26m despite revenues that grew -- from 0.00 to 129.00k.
| Gross margin | 62.39% |
|---|---|
| Net profit margin | -1,748.79% |
| Operating margin | -1,748.79% |
| Return on assets | -55.60% |
|---|---|
| Return on equity | -170.16% |
| Return on investment | -144.62% |
More ▼
Cash flow in AUDView more
In 2024, Cambium Bio Ltd increased its cash reserves by 846.18%, or 2.56m. Cash Flow from Financing totalled 3.13m or 2,429.57% of revenues. In addition the company used 155.86k for operations while cash used for investing totalled 416.13k.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.2327 |
|---|---|
| Tangible book value per share | 0.0274 |
More ▼
Balance sheet in AUDView more
| Current ratio | 1.33 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.1687 |
|---|---|
| Total debt/total capital | 0.1443 |
More ▼
